| 1. |
|
|
| 2. |
- Mishra, A, et al.
(författare)
-
Diminishing benefits of urban living for children and adolescents' growth and development
- 2023
-
Ingår i: Nature. - : Springer Science and Business Media LLC. - 1476-4687 .- 0028-0836. ; 615:7954, s. 874-883
-
Tidskriftsartikel (refereegranskat)abstract
- Optimal growth and development in childhood and adolescence is crucial for lifelong health and well-being1–6. Here we used data from 2,325 population-based studies, with measurements of height and weight from 71 million participants, to report the height and body-mass index (BMI) of children and adolescents aged 5–19 years on the basis of rural and urban place of residence in 200 countries and territories from 1990 to 2020. In 1990, children and adolescents residing in cities were taller than their rural counterparts in all but a few high-income countries. By 2020, the urban height advantage became smaller in most countries, and in many high-income western countries it reversed into a small urban-based disadvantage. The exception was for boys in most countries in sub-Saharan Africa and in some countries in Oceania, south Asia and the region of central Asia, Middle East and north Africa. In these countries, successive cohorts of boys from rural places either did not gain height or possibly became shorter, and hence fell further behind their urban peers. The difference between the age-standardized mean BMI of children in urban and rural areas was <1.1 kg m–2 in the vast majority of countries. Within this small range, BMI increased slightly more in cities than in rural areas, except in south Asia, sub-Saharan Africa and some countries in central and eastern Europe. Our results show that in much of the world, the growth and developmental advantages of living in cities have diminished in the twenty-first century, whereas in much of sub-Saharan Africa they have amplified.
|
|
| 3. |
- Charalampous, P., et al.
(författare)
-
Methodological considerations in injury burden of disease studies across Europe: a systematic literature review
- 2022
-
Ingår i: Bmc Public Health. - : Springer Science and Business Media LLC. - 1471-2458. ; 22:1
-
Forskningsöversikt (refereegranskat)abstract
- Background Calculating the disease burden due to injury is complex, as it requires many methodological choices. Until now, an overview of the methodological design choices that have been made in burden of disease (BoD) studies in injury populations is not available. The aim of this systematic literature review was to identify existing injury BoD studies undertaken across Europe and to comprehensively review the methodological design choices and assumption parameters that have been made to calculate years of life lost (YLL) and years lived with disability (YLD) in these studies. Methods We searched EMBASE, MEDLINE, Cochrane Central, Google Scholar, and Web of Science, and the grey literature supplemented by handsearching, for BoD studies. We included injury BoD studies that quantified the BoD expressed in YLL, YLD, and disability-adjusted life years (DALY) in countries within the European Region between early-1990 and mid-2021. Results We retrieved 2,914 results of which 48 performed an injury-specific BoD assessment. Single-country independent and Global Burden of Disease (GBD)-linked injury BoD studies were performed in 11 European countries. Approximately 79% of injury BoD studies reported the BoD by external cause-of-injury. Most independent studies used the incidence-based approach to calculate YLDs. About half of the injury disease burden studies applied disability weights (DWs) developed by the GBD study. Almost all independent injury studies have determined YLL using national life tables. Conclusions Considerable methodological variation across independent injury BoD assessments was observed; differences were mainly apparent in the design choices and assumption parameters towards injury YLD calculations, implementation of DWs, and the choice of life table for YLL calculations. Development and use of guidelines for performing and reporting of injury BoD studies is crucial to enhance transparency and comparability of injury BoD estimates across Europe and beyond.
|
|
| 4. |
- Orce, J. N., et al.
(författare)
-
Reorientation-effect measurement of the (2+ 1 Eˆ22+ 1) matrix element in 10Be
- 2012
-
Ingår i: Physical Review C - Nuclear Physics. - 2469-9985 .- 2469-9993. ; 86:4
-
Tidskriftsartikel (refereegranskat)abstract
- The highly-efficient and segmented TIGRESS gamma-ray spectrometer at TRIUMF has been used to perform a reorientation-effect Coulomb-excitation study of the 2(1)(+) state at 3.368 MeV in Be-10. This is the first Coulomb-excitation measurement that enables one to obtain information on diagonal matrix elements for such a high-lying first excited state from gamma-ray data. With the availability of accurate lifetime data, a value of -0.110 +/- 0.087 eb is determined for the diagonal matrix element, which assuming the rotor model, leads to a negative spectroscopic quadrupole moment of Q(S)(2(1)(+)) = -0.083 +/- 0.066 eb. This result is in agreement with both no-core shell-model calculations performed in this work with the CD-Bonn 2000 two-nucleon potential and large shell-model spaces, and Green's function Monte Carlo predictions with two-plus three-nucleon potentials.
|
|
| 5. |
- Bel Lassen, P., et al.
(författare)
-
Protein intake, metabolic status and the gut microbiota in different ethnicities: Results from two independent cohorts
- 2021
-
Ingår i: Nutrients. - : MDPI AG. - 2072-6643. ; 13:9
-
Tidskriftsartikel (refereegranskat)abstract
- Background: Protein intake has been associated with the development of pre-diabetes (pre-T2D) and type 2 diabetes (T2D). The gut microbiota has the capacity to produce harmful metabolites derived from dietary protein. Furthermore, both the gut microbiota composition and metabolic status (e.g., insulin resistance) can be modulated by diet and ethnicity. However, to date most studies have predominantly focused on carbohydrate and fiber intake with regards to metabolic status and gut microbiota composition. Objectives: To determine the associations between dietary protein intake, gut microbiota composition, and metabolic status in different ethnicities. Methods: Separate cross-sectional analysis of two European cohorts (MetaCardis, n = 1759; HELIUS, n = 1528) including controls, patients with pre-T2D, and patients with T2D of Caucasian/non-Caucasian origin with nutritional data obtained from Food Frequency Questionnaires and gut microbiota composition. Results: In both cohorts, animal (but not plant) protein intake was associated with pre-T2D status and T2D status after adjustment for confounders. There was no significant association between protein intake (total, animal, or plant) with either gut microbiota alpha diversity or beta diversity, regardless of ethnicity. At the species level, we identified taxonomical signatures associated with animal protein intake that overlapped in both cohorts with different abundances according to metabolic status and ethnicity. Conclusions: Animal protein intake is associated with pre-T2D and T2D status but not with gut microbiota beta or alpha diversity, regardless of ethnicity. Gut microbial taxonomical signatures were identified, which could function as potential modulators in the association between dietary protein intake and metabolic status. © 2021 by the authors. Licensee MDPI, Basel, Switzerland.
|
|
| 6. |
|
|
| 7. |
- Govaere, O., et al.
(författare)
-
Macrophage scavenger receptor 1 mediates lipid-induced inflammation in non-alcoholic fatty liver disease
- 2022
-
Ingår i: Journal of Hepatology. - : Elsevier BV. - 0168-8278 .- 1600-0641. ; 76:5, s. 1001-1012
-
Tidskriftsartikel (refereegranskat)abstract
- Background & Aims: Obesity-associated inflammation is a key player in the pathogenesis of non-alcoholic fatty liver disease (NAFLD). However, the role of macrophage scavenger receptor 1 (MSR1, CD204) remains incompletely understood. Methods: A total of 170 NAFLD liver biopsies were processed for transcriptomic analysis and correlated with clinicopathological features. Msr1-/- and wild-type mice were subjected to a 16-week high-fat and high-cholesterol diet. Mice and ex vivo human liver slices were treated with a monoclonal antibody against MSR1. Genetic susceptibility was assessed using genome-wide association study data from 1,483 patients with NAFLD and 430,101 participants of the UK Biobank. Results: MSR1 expression was associated with the occurrence of hepatic lipid-laden foamy macrophages and correlated with the degree of steatosis and steatohepatitis in patients with NAFLD. Mice lacking Msr1 were protected against diet-induced metabolic disorder, showing fewer hepatic foamy macrophages, less hepatic inflammation, improved dyslipidaemia and glucose tolerance, and altered hepatic lipid metabolism. Upon induction by saturated fatty acids, MSR1 induced a pro-inflammatory response via the JNK signalling pathway. In vitro blockade of the receptor prevented the accumulation of lipids in primary macrophages which inhibited the switch towards a pro-inflammatory phenotype and the release of cytokines such as TNF-ɑ. Targeting MSR1 using monoclonal antibody therapy in an obesity-associated NAFLD mouse model and human liver slices resulted in the prevention of foamy macrophage formation and inflammation. Moreover, we identified that rs41505344, a polymorphism in the upstream transcriptional region of MSR1, was associated with altered serum triglycerides and aspartate aminotransferase levels in a cohort of over 400,000 patients. Conclusions: Taken together, our data suggest that MSR1 plays a critical role in lipid-induced inflammation and could thus be a potential therapeutic target for the treatment of NAFLD. Lay summary: Non-alcoholic fatty liver disease (NAFLD) is a chronic disease primarily caused by excessive consumption of fat and sugar combined with a lack of exercise or a sedentary lifestyle. Herein, we show that the macrophage scavenger receptor MSR1, an innate immune receptor, mediates lipid uptake and accumulation in Kupffer cells, resulting in liver inflammation and thereby promoting the progression of NAFLD in humans and mice. © 2021 The Authors
|
|
| 8. |
|
|
| 9. |
- Gorasso, Vanessa, et al.
(författare)
-
Burden of disease attributable to risk factors in European countries: a scoping literature review
- 2023
-
Ingår i: Archives of Public Health. - 0778-7367 .- 2049-3258. ; 81:1
-
Forskningsöversikt (refereegranskat)abstract
- Objectives: Within the framework of the burden of disease (BoD) approach, disease and injury burden estimates attributable to risk factors are a useful guide for policy formulation and priority setting in disease prevention. Considering the important differences in methods, and their impact on burden estimates, we conducted a scoping literature review to: (1) map the BoD assessments including risk factors performed across Europe; and (2) identify the methodological choices in comparative risk assessment (CRA) and risk assessment methods. Methods: We searched multiple literature databases, including grey literature websites and targeted public health agencies websites. Results: A total of 113 studies were included in the synthesis and further divided into independent BoD assessments (54 studies) and studies linked to the Global Burden of Disease (59 papers). Our results showed that the methods used to perform CRA varied substantially across independent European BoD studies. While there were some methodological choices that were more common than others, we did not observe patterns in terms of country, year or risk factor. Each methodological choice can affect the comparability of estimates between and within countries and/or risk factors, since they might significantly influence the quantification of the attributable burden. From our analysis we observed that the use of CRA was less common for some types of risk factors and outcomes. These included environmental and occupational risk factors, which are more likely to use bottom-up approaches for health outcomes where disease envelopes may not be available. Conclusions: Our review also highlighted misreporting, the lack of uncertainty analysis and the under-investigation of causal relationships in BoD studies. Development and use of guidelines for performing and reporting BoD studies will help understand differences, avoid misinterpretations thus improving comparability among estimates.
|
|
| 10. |
- Henderson, J., et al.
(författare)
-
Coulomb excitation of the vertical bar T-z vertical bar=1/2, A=23 mirror pair
- 2022
-
Ingår i: PHYSICAL REVIEW C. - 2469-9985 .- 2469-9993. ; 105:3
-
Tidskriftsartikel (refereegranskat)abstract
- Background: Electric-quadrupole (E2) strengths relate to the underlying quadrupole deformation of a nucleus and present a challenge for many nuclear theories. Mirror nuclei in the vicinity of the line of N = Z represent a convenient laboratory for testing deficiencies in such models, making use of the isospin symmetry of the systems. Purpose: Uncertainties associated with literature E2 strengths in Mg-23 are some of the largest in T-z = vertical bar 1/2 vertical bar nuclei in the sd shell. The purpose of the present paper is to improve the precision with which these values are known, to enable better comparison with theoretical models. Methods: Coulomb-excitation measurements of Mg-23 and Na-23 were performed at the TRIUMF-ISAC facility using the TIGRESS spectrometer. They were used to determine the E2 matrix elements of mixed E2/M1 transitions. Results: Reduced E2 transition strengths, B(E2), were extracted for Mg-23 and Na-23. Their precision was improved by factors of approximately 6 for both isotopes, while agreeing within uncertainties with previous measurements. Conclusions: A comparison was made with both shell-model and ab initio valence-space in-medium similarity renormalization group calculations. Valence-space in-medium similarity renormalization group calculations were found to underpredict the absolute E2 strength, in agreement with previous studies.
|
|
| 11. |
|
|
| 12. |
|
|
| 13. |
|
|
| 14. |
|
|
| 15. |
|
|
| 16. |
|
|
| 17. |
- Byskov, Camilla S., et al.
(författare)
-
Treatment plan comparison of proton vs photon radiotherapy for lower-grade gliomas
- 2021
-
Ingår i: Physics and Imaging in Radiation Oncology. - : Elsevier. - 2405-6316. ; 20, s. 98-104
-
Tidskriftsartikel (refereegranskat)abstract
- Background and purpose: Patients with lower-grade gliomas are long-term survivors after radiotherapy and may benefit from the reduced dose to normal tissue achievable with proton therapy. Here, we aimed to quantify differences in dose to the uninvolved brain and contralateral hippocampus and compare the risk of radiation-induced secondary cancer for photon and proton plans for lower-grade glioma patients. Materials and methods: Twenty-three patients were included in this in-silico planning comparative study and had photon and proton plans calculated (50.4 Gy(RBE = 1.1), 28 Fx) applying similar dose constraints to the target and organs at risk. Automatically calculated photon plans were generated with a 3 mm margin from clinical target volume (CTV) to planning target volume. Manual proton plans were generated using robust optimisation on the CTV. Dose metrics of organs at risk were compared using population mean dose-volume histograms and Wilcoxon signed-rank test. Secondary cancer risk per 10,000 persons per year (PPY) was estimated using dose-volume data and a risk model for secondary cancer induction. Results: CTV coverage (V95%>98%) was similar for the two treatment modalities. Mean dose (D-mean) to the uninvolved brain was significantly reduced from 21.5 Gy (median, IQR 17.1-24.4 Gy) with photons compared to 10.3 Gy(RBE) (8.1-13.9 Gy(RBE)) with protons. D-mean to the contralateral hippocampus was significantly reduced from 6.5 Gy (5.4-11.7 Gy) with photons to 1.5 Gy(RBE) (0.4-6.8 Gy(RBE)) with protons. The estimated secondary cancer risk was reduced from 6.7 PPY (median, range 3.3-10.4 PPY) with photons to 3.0 PPY (1.3-7.5 PPY) with protons. Conclusion: A significant reduction in mean dose to uninvolved brain and contralateral hippocampus was found with proton planning. The estimated secondary cancer risk was reduced with proton therapy.
|
|
| 18. |
|
|
| 19. |
- Dahl, O. E., et al.
(författare)
-
Major joint replacement. A model for antithrombotic drug development: from proof-of-concept to clinical use
- 2008
-
Ingår i: International angiology. - 0392-9590. ; 27:1, s. 60-7
-
Tidskriftsartikel (refereegranskat)abstract
- AIM: Development of antithrombotic compounds has traditionally been performed in patients undergoing total hip and knee replacement surgery. A high number of asymptomatic deep-vein thromboses are radiologically detectable, and bleeding and other adverse events (AE) are easy to observe. However, standardization of study procedures and endpoints in early proof-of-concept studies and late pure clinical endpoint studies has been lacking. This has made comparison between studies difficult, economic analyses speculative and potential benefits of applying the drug regimen in non-selected patients uncertain. In this paper, the International Surgical Thrombosis Forum proposes a strategy for the clinical investigation of new pharmacological agents for the prophylaxis of postoperative thrombotic events. METHODS: First, dose titration safety studies of short duration, in highly selected patients using objective venographic endpoints are recommended. Bleeding should be divided into the quantified volume of surgical bleeding and other adjudicated clinical bleeding events. The number of AE should be described for each dose step and classified according to International Coding of Diagnoses (ICD). Second, a dose confirmatory study of moderate exposure period and sufficient follow-up time is recommended. The exclusion criteria should be restricted to contraindications of the compared drugs and technical procedure. RESULTS: The efficacy, bleeding and AE should be similar to those used in dose-titration studies. In addition, the failure rate of the drug to exert its effect and the net clinical benefit should be calculated. CONCLUSION: Finally, trials with simple clinical endpoints and long follow-up should be conducted to evaluate the potential benefits of the drug-regimen in non-selected populations.
|
|
| 20. |
|
|
| 21. |
- Ebefors, Kerstin, 1977, et al.
(författare)
-
Modeling the Glomerular Filtration Barrier and Intercellular Crosstalk
- 2021
-
Ingår i: Frontiers in Physiology. - : Frontiers Media SA. - 1664-042X. ; 12
-
Tidskriftsartikel (refereegranskat)abstract
- The glomerulus is a compact cluster of capillaries responsible for blood filtration and initiating urine production in the renal nephrons. A trilaminar structure in the capillary wall forms the glomerular filtration barrier (GFB), composed of glycocalyx-enriched and fenestrated endothelial cells adhering to the glomerular basement membrane and specialized visceral epithelial cells, podocytes, forming the outermost layer with a molecular slit diaphragm between their interdigitating foot processes. The unique dynamic and selective nature of blood filtration to produce urine requires the functionality of each of the GFB components, and hence, mimicking the glomerular filter in vitro has been challenging, though critical for various research applications and drug screening. Research efforts in the past few years have transformed our understanding of the structure and multifaceted roles of the cells and their intricate crosstalk in development and disease pathogenesis. In this review, we present a new wave of technologies that include glomerulus-on-a-chip, three-dimensional microfluidic models, and organoids all promising to improve our understanding of glomerular biology and to enable the development of GFB-targeted therapies. Here, we also outline the challenges and the opportunities of these emerging biomimetic systems that aim to recapitulate the complex glomerular filter, and the evolving perspectives on the sophisticated repertoire of cellular signaling that comprise the glomerular milieu.
|
|
| 22. |
- Hannemann, P, et al.
(författare)
-
Patterns in current anaesthesiological peri-operative practice for colonic resections : a survey in five northern-European countries
- 2006
-
Ingår i: Acta Anaesthesiologica Scandinavica. - Oxon, United Kingdom : Blackwell Publishing. - 0001-5172 .- 1399-6576. ; 50:9, s. 1152-60
-
Tidskriftsartikel (refereegranskat)abstract
- Background: For colorectal surgery, evidence suggests that optimal management includes: no pre-operative fasting, a thoracic epidural analgesia continued for 2 days post-operatively, and avoidance of fluid overload. In addition, no long-acting benzodiazepines on the day of surgery and use of short-acting anaesthetic medication may be beneficial. We examined whether these strategies have been adopted in five northern-European countries.Methods: In 2003, a questionnaire concerning peri-operative anaesthetic routines in elective, open colonic cancer resection was sent to the chief anaesthesiologist in 258 digestive surgical centres in Scotland, the Netherlands, Denmark, Sweden and Norway.Results: The response rate was 74% (n = 191). Although periods of pre-operative fasting up to 48 h were reported, most (> 85%) responders in all countries declared to adhere to guidelines for pre-operative fasting and oral clear liquids were permitted until 2-3 h before anaesthesia. Solid food was permitted up to 6-8 h prior to anaesthesia. In all countries more than 85% of the responders indicated that epidural anaesthesia was routinely used. Except for Denmark, long-acting benzodiazepines were still widely used. Short-acting anaesthetics were used in all countries except Scotland where isoflurane is the anaesthetic of choice. With the exception of Denmark, intravenous fluids were used unrestrictedly.Conclusion: In northern Europe, most anaesthesiologists adhere to evidence-based optimal management strategies on pre-operative fasting, thoracic epidurals and short-acting anaesthetics. However, premedication with longer-acting agents is still common. Avoidance of fluid overload has not yet found its way into daily practice. This may leave patients undergoing elective colonic surgery at risk of oversedation and excessive fluid administration with potential adverse effects on surgical outcome.
|
|
| 23. |
|
|
| 24. |
|
|
| 25. |
|
|
| 26. |
- Jensen, Jan S., et al.
(författare)
-
Safety in simple versus complex stenting of coronary artery bifurcation lesions : The nordic bifurcation study 14-month follow-up results
- 2008
-
Ingår i: EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology. - 1774-024X. ; 4:2, s. 229-233
-
Tidskriftsartikel (refereegranskat)abstract
- AIMS: The risk of stent thrombosis has been reported to increase with percutaneous coronary intervention (PCI) complexity. The present study reports the pre-specified secondary endpoint of a 14-month stent thrombosis and major adverse cardiac events in patients stented with a simple versus a complex bifurcation technique using sirolimus eluting stents (SES). METHODS AND RESULTS: A total of 413 patients with a coronary bifurcation lesion were randomised to a simple treatment strategy; stenting of main vessel and optional stenting of side branch (MV group), or to a complex stenting strategy; stenting of both main vessel and side branch (MV+SB group). Mortality data were available in all patients and 14-month clinical follow-up data in 395 (96%) of the patients. After 14 months, the rates of definite, probable and possible stent thrombosis (ARC criteria) were 1.0% vs. 0.5%, 1.0% vs. 0% and 0.5% vs. 0% (ns) in the MV and in the MV+SB groups, respectively. Rates of MACE were 9.5% in the MV group and 8.2% in the MV+SB group (ns). Total death was seen in 2.4% vs. 1.0% and non-PCI related myocardial infarction in 2.0% vs. 1.0% in the MV and the MV+SB groups, respectively. CONCLUSIONS: After 14 months, two months after recommended cessation of dual antiplatelet therapy, the rates of stent thrombosis and major adverse cardiac events were low and independent of treatment complexity in patients treated with SES for coronary artery bifurcation lesions.
|
|
| 27. |
|
|
| 28. |
- Klimov, A. B., et al.
(författare)
-
Assessing the Polarization of a Quantum Field from Stokes Fluctuations
- 2010
-
Ingår i: Physical Review Letters. - 0031-9007 .- 1079-7114. ; 105:15, s. 153602-
-
Tidskriftsartikel (refereegranskat)abstract
- We propose an operational degree of polarization in terms of the variance of the Stokes vector minimized over all the directions of the Poincare sphere. We examine the properties of this second-order definition and carry out its experimental determination. Quantum states with the same standard (first-order) degree of polarization are correctly discriminated by this new measure. We argue that a comprehensive quantum characterization of polarization properties requires a whole hierarchy of higher-order degrees.
|
|
| 29. |
|
|
| 30. |
|
|
| 31. |
- Lassen, M R, et al.
(författare)
-
The effects of rivaroxaban on the complications of surgery after total hip or knee replacement: Results from the RECORD programme.
- 2012
-
Ingår i: The Journal of bone and joint surgery. British volume. - 0301-620X. ; 94:11, s. 1573-8
-
Tidskriftsartikel (refereegranskat)abstract
- Post-operative complications after total hip or knee replacement can delay recovery, prolong hospitalisation, increase rates of re-admission and, in the most severe cases, lead to long-term disability or even death. In this analysis of pooled data from four large, randomised, phase III clinical trials that compared the oral, direct Factor Xa inhibitor rivaroxaban with subcutaneous enoxaparin for the prevention of venous thromboembolism after total hip or knee replacement (n = 12729), the incidence of complications, including bleeding and adverse events related to surgery (such as wound infection, wound dehiscence and haemarthrosis) are reported. Interventions and procedures relating to surgery are also compared between the groups. Bleeding events, including excessive wound haematoma and surgical-site bleeding, occurred at similar rates in the rivaroxaban and enoxaparin groups. Over the total study duration, adverse surgical events occurred at a similar rate in the rivaroxaban group compared with the enoxaparin group after total knee replacement (2.26% vs 2.69%, respectively) and total hip replacement (1.48% vs 1.65%, respectively). Blood loss, wound drainage and transfusion requirements were also similar between the two groups. This analysis shows that the incidence of adverse surgical events with rivaroxaban was similar to enoxaparin.
|
|
| 32. |
|
|
| 33. |
|
|
| 34. |
|
|
| 35. |
- Maeng, Michael, et al.
(författare)
-
Long-Term Results After Simple Versus Complex Stenting of Coronary Artery Bifurcation Lesions : Nordic Bifurcation Study 5-Year Follow-Up Results
- 2013
-
Ingår i: Journal of the American College of Cardiology. - : Elsevier BV. - 0735-1097 .- 1558-3597. ; 62:1, s. 30-34
-
Tidskriftsartikel (refereegranskat)abstract
- Objectives This study sought to report the 5-year follow-up results of the Nordic Bifurcation Study. Background Randomized clinical trials with short-term follow-up have indicated that coronary bifurcation lesions may be optimally treated using the optional side branch stenting strategy. Methods A total of 413 patients with a coronary bifurcation lesion were randomly assigned to a simple stenting strategy of main vessel (MV) and optional stenting of side branch (SB) or to a complex stenting strategy, namely, stenting of both MV and SB. Results Five-year clinical follow-up data were available for 404 (98%) patients. The combined safety and efficacy endpoint of cardiac death, non-procedure-related myocardial infarction, and target vessel revascularization were seen in 15.8% in the optional SB stenting group as compared to 21.8% in the MV and SB stenting group (p = 0.15). All-cause death was seen in 5.9% versus 10.4% (p = 0.16) and non-procedure-related myocardial infarction in 4% versus 7.9% (p = 0.09) in the optional SB stenting group versus the MV and SB stenting group, respectively. The rates of target vessel revascularization were 13.4% versus 18.3% (p = 0.14) and the rates of definite stent thrombosis were 3% versus 1.5% (p = 0.31) in the optional SB stenting group versus the MV and SB stenting group, respectively. Conclusions At 5-year follow-up in the Nordic Bifurcation Study, the clinical outcomes after simple optional side branch stenting remained at least equal to the more complex strategy of planned stenting of both the main vessel and the side branch.
|
|
| 36. |
|
|
| 37. |
- Moros, M, et al.
(författare)
-
Were glacial iceberg surges in the North Atlantic triggered by climatic warming?
- 2002
-
Ingår i: Marine Geology. - 0025-3227. ; 192:4, s. 393-417
-
Tidskriftsartikel (refereegranskat)abstract
- High-resolution physical, mineralogical, sedimentological and micropalaeontological studies were carried out on North Atlantic cores from the Reykjanes Ridge at 59degreesN and from the region southwest of the Faeroe Islands. All core sites are situated along the pathway of Iceland-Scotland Overflow Water (ISOW) and the various parameters measured display similar features. Previously identified carbonate oscillations [Keigwin and Jones (1994) J. Geophys. Res., 99, 12397-12410] in the time span back to the Marine Isotope Stage 5-4 transition and Late Glacial lithic events [Bond and Lotti (1995) Science, 267, 1005-1010], such as the Heinrich ice-rafting events, are all represented in the core records. Long-term trends and higher-frequency changes in ISOW intensity were reconstructed on the basis of various independent proxy records. The long-term trends in circulation match theoretical orbitally forced insolation changes. Our observed links between ice-rafted detritus (IRD) input, variations in sea surface temperature (SST) and circulation at greater depth point to the need to re-examine the origin of IRD events. We suggest that these events may have been triggered by enhanced, partly sub-surface, heat transport to the-north. Enhanced northward heat transport may have caused bottom melting of floating outlet glaciers and ice shelves, leading to increased iceberg discharge and ice sheet destabilization. This discharge. resulted in lower SST's and a lower temperature over Greenland. Thus, as shown by our records, this scenario implies a temporary de-coupling of surface processes and circulation at greater depth. A key feature is the occurrence of a-saw-tooth pattern in the marine data, which is similar to the Greenland ice core records. Moreover, the 'warming' theory of IRD events would explain the observed 'out-of-phase' relationship between the Greenland and Antarctic ice-core records and also the rapid establishment of higher temperatures over Greenland immediately after the cold phases (stadials) of the Dansgaard-Oeschger cycles.
|
|
| 38. |
|
|
| 39. |
|
|
| 40. |
|
|
| 41. |
- Niemelä, Matti, et al.
(författare)
-
Randomized Comparison of Final Kissing Balloon Dilatation Versus No Final Kissing Balloon Dilatation in Patients With Coronary Bifurcation Lesions Treated With Main Vessel Stenting : The nordic-baltic bifurcation study III
- 2011
-
Ingår i: Circulation. - 0009-7322 .- 1524-4539. ; 123:1, s. 79-86
-
Tidskriftsartikel (refereegranskat)abstract
- Background-It is unknown whether the preferred 1-stent bifurcation stenting approach with stenting of the main vessel (MV) and optional side branch stenting using drug-eluting stents should be finalized by a kissing balloon dilatation (FKBD). Therefore, we compared strategies of MV stenting with and without FKBD. Methods and Results-We randomized 477 patients with a bifurcation lesion to FKBD (n=238) or no FKBD (n=239) after MV stenting. The primary end point was major adverse cardiac events: cardiac death, non-procedure-related index lesion myocardial infarction, target lesion revascularization, or stent thrombosis within 6 months. The 6-month major adverse cardiac event rates were 2.1% and 2.5% (P=1.00) in the FKBD and no-FKBD groups, respectively. Procedure and fluoroscopy times were longer and more contrast media was needed in the FKBD group than in the no-FKBD group. Three hundred twenty-six patients had a quantitative coronary assessment. At 8 months, the rate of binary (re) stenosis in the entire bifurcation lesion (MV and side branch) was 11.0% versus 17.3% (P=0.11), in the MV was 3.1% versus 2.5% (P=0.68), and in the side branch was 7.9% versus 15.4% (P=0.039) in the FKBD versus no-FKBD groups, respectively. In patients with true bifurcation lesions, the side branch restenosis rate was 7.6% versus 20.0% (P=0.024) in the FKBD and no-FKBD groups, respectively. Conclusions-MV stenting strategies with and without FKBD were associated with similar clinical outcomes. FKBD reduced angiographic side branch (re) stenosis, especially in patients with true bifurcation lesions. The simple no-FKBD procedures resulted in reduced use of contrast media and shorter procedure and fluoroscopy times. Long-term data on stent thrombosis are needed. Clinical Trial Registration-URL: http://clinicaltrials.gov. Unique identifier: NCT00914199. (Circulation. 2011;123:79-86.)
|
|
| 42. |
|
|
| 43. |
- Nordvall-Lassen, M., et al.
(författare)
-
Leisure time physical activity in 9- to 11-year-old children born moderately preterm : A cohort study
- 2018
-
Ingår i: BMC Pediatrics. - : Springer Science and Business Media LLC. - 1471-2431. ; 18:1
-
Tidskriftsartikel (refereegranskat)abstract
- Background: Physical activity is one of the best documented activities with impacts on health in children and adults. Children born preterm show reduced physical and psychosocial function compared to children born at term. This may influence their level of physical activity. Reports on moderately preterm children's physical activities during childhood are limited. Thus, the aim of this study was to compare the leisure time physical activity at age 9-11years of moderately preterm children with that of children born at term. Methods: Data from 4941 mother-child pairs from the Aarhus Birth Cohort (1989-91) were used. The cohort gathered clinical information, including gestational age at delivery. Information about parental socio-demographic and lifestyle factors was obtained from questionnaires completed during the second trimester of pregnancy. Information about children's physical activities was reported in a 9- to 11-year follow-up questionnaire completed by parents detailing how many times per week their child participated in sports activities outside of school, hours spent per week playing outside, and hours per week engaged in sedentary activities. Data were analysed using multiple logistic regression with the lowest activity group as a reference group. Results: A total of 158 children (3.2%) were born moderately preterm, i.e., between 32 and 36 completed weeks. Children born moderately preterm participated in sports activities as often as their peers born at term; they also participated in frequent sports activities (≥ 4 times per week) as often as their peers. There were no differences in hours per week spent playing outside or in sedentary activities between the two groups. Conclusions: Nine- to 11-year-old moderately preterm children participated in sports activities outside school to a similar extent as their peers and engaged in outdoor activities and sedentary activities for the same duration of time per week as their peers born at term.
|
|
| 44. |
|
|
| 45. |
- Rafaeva, Maria, et al.
(författare)
-
Modeling Metastatic Colonization in a Decellularized Organ Scaffold-Based Perfusion Bioreactor
- 2022
-
Ingår i: Advanced healthcare materials. - : Wiley. - 2192-2640 .- 2192-2659. ; 11:1
-
Tidskriftsartikel (refereegranskat)abstract
- Metastatic cancer spread is responsible for most cancer-related deaths. To colonize a new organ, invading cells adapt to, and remodel, the local extracellular matrix (ECM), a network of proteins and proteoglycans underpinning all tissues, and a critical regulator of homeostasis and disease. However, there is a major lack in tools to study cancer cell behavior within native 3D ECM. Here, an in-house designed bioreactor, where mouse organ ECM scaffolds are perfused and populated with cells that are challenged to colonize it, is presented. Using a specialized bioreactor chamber, it is possible to monitor cell behavior microscopically (e.g., proliferation, migration) within the organ scaffold. Cancer cells in this system recapitulate cell signaling observed in vivo and remodel complex native ECM. Moreover, the bioreactors are compatible with co-culturing cell types of different genetic origin comprising the normal and tumor microenvironment. This degree of experimental flexibility in an organ-specific and 3D context, opens new possibilities to study cell–cell and cell–ECM interplay and to model diseases in a controllable organ-specific system ex vivo.
|
|
| 46. |
- Rasmussen, Tine, et al.
(författare)
-
The Faroe-Shetland Gateway: Late Quaternary water mass exchange between the Nordic seas and the northeastern Atlantic
- 2002
-
Ingår i: Marine Geology. - 0025-3227. ; 188:1-2, s. 165-192
-
Tidskriftsartikel (refereegranskat)abstract
- Thirteen piston and gravity cores from the Faroe-Shetland area were investigated for their planktic and benthic foraminiferal and oxygen isotopic distributions. Eight time-slices between 18 ka BP and the present were reconstructed to study variations in surface and deep water exchange between the SE Norwegian Sea and the northeast Atlantic Ocean. Today, a relatively strong northward flow of warm North Atlantic surface water is counterbalanced by a southward outflow of newly convected cold bottom water, the Norwegian Sea Overflow Water. During the last glacial maximum at 18 ka BP both the surface and bottom flows were slow and the climate conditions were Arctic. The convection north of the Faroe area was weak and unstable. The first indication of the deglaciation is a decrease in the planktic oxygen isotope values discernible southwest of the Faroe Islands at 15.5 ka BP. The deglaciation proceeded northeast and eastward synchronous with a gradual intensification of northward flowing warmer Atlantic Intermediate Water along the sea bottom. Meltwater fluxes increased between 14 and 13 ka BP producing cold surface waters, and the climatic cooling was extreme. There was no southward overflow of cold bottom water during this time period and the exchange of water masses between the Nordic seas and the North Atlantic Ocean was essentially reversed, i.e. estuarine. During the Bolling Interstadial at 12.5 ka BP northward flowing warm surface water was present to the east of the Faroe-Shetland Channel, wedged below a tongue of polar water spreading from the northwest and reaching into the Faroe-Shetland Channel. Convection in the Nordic seas and overflow of cold deep water started during the Bolling Interstadial. The polar water spread more eastward and southward during the following cold spell, the Younger Dryas, around 10.3 ka BP. The polar water was overlying the warmer, but more saline Atlantic water, which flowed northward below the cold surface water. The overflow of cold bottom water was supposedly only slightly weaker than during the Bolling Interstadial. Strong inflow of warm surface water took place during the Early Holocene at 9.5 ka BP and relatively dense cold water flowed southward along the bottom. The rate of water mass exchange reached a maximum at 6.5 ka BP, when both the inflow of warm Atlantic surface water and the outflow of cold dense bottom water appear to have been stronger than today.
|
|
| 47. |
- Schulman, S., et al.
(författare)
-
Definition of major bleeding in clinical investigations of antihemostatic medicinal products in surgical patients
- 2010
-
Ingår i: Journal of Thrombosis and Haemostasis. - : Elsevier BV. - 1538-7933 .- 1538-7836. ; 8:1, s. 202-204
-
Tidskriftsartikel (refereegranskat)abstract
- The definition of major bleeding varies between studies on surgical patients, particularly regarding the criteria for surgical wound-related bleeding. This diversity contributes to the difficulties in comparing data between trials. The Scientific and Standardization Committee (SSC), through its subcommittee on Control of Anticoagulation, of the International Society on Thrombosis and Haemostasis has previously published a recommendation for a harmonized definition of major bleeding in non-surgical studies. That definition has been adopted by the European Medicines Agency and is currently used in several non-surgical trials. A preliminary proposal for a parallel definition for surgical studies was presented at the 54(th) Annual Meeting of the SSC in Vienna, July 2008. Based on those discussions and further consultations with European and North American surgeons with experience from clinical trials a definition has been developed that should be applicable to all agents that interfere with hemostasis. The definition and the text that follows have been reviewed and approved by relevant co-chairs of the subcommittee and by the Executive Committee of the SSC. The intention is to seek approval of this definition from the regulatory authorities to enhance its incorporation into future clinical trial protocols.
|
|
| 48. |
- Schulman, S, et al.
(författare)
-
Response to rebuttal, definition of major bleeding in surgery: an anaesthesiologist's point of view.
- 2010
-
Ingår i: Journal of thrombosis and haemostasis. - : Elsevier BV. - 1538-7836 .- 1538-7933. ; 8:6, s. 1443-1444
-
Tidskriftsartikel (refereegranskat)abstract
- See also Schulman S, Angeras U, Bergqvist D, Eriksson B, Lassen MR, Fisher W. Definition of major bleeding in clinical investigations of anti-hemostatic medicinal products in surgical patients. J Thromb Haemost 2010; 8: 202–4; Rosencher N, Zufferey P, Samama C-M. Definition of major bleeding in surgery: an anesthesiologist's point of view: a rebuttal. This issue, pp 1442–3. We read with interest the comments by Rosencher et al. about our definition of major bleeding in surgical patients. The component of our definition that is the focus of this discussion is criterion 5, i.e. the unexpected bleeding with some additional requirements [1]. We are aware that anesthesiologists frequently make use of more detailed calculations of blood loss. Their way of calculating blood loss is certainly more accurate than the criterion of a defined drop in hemoglobin or the need for 2 or more units of blood transfusion. In theory, such calculations are physiologically relevant for the decision to give a blood transfusion and may, therefore, result in more appropriate and hopefully reduced use of blood transfusions as indicated in the OSTHEO study [2]. However, criteria that are based on blood loss calculations have never been used for recognition of major bleeding. One of us (B.E.) evaluated blood loss, transfusion requirement and delta-hemoglobin in phase II studies on desirudin and melagatran. These variables had a lower sensitivity than the surgeon’s subjective view of ’serious bleeding‘ or ’overt bleeding‘ in the dose response of these anticoagulants. There is thus insufficient evidence to propose that calculated blood loss could be superior to differentiate between drug-induced and surgical bleeding. The European Medicines Agency (EMEA) guideline from 2007 (printed 2008) [3] is the one we want to improve and correct with our set of definitions. That guideline primarily uses the criteria defined by ISTH for medical patients. As additional support, calculated blood loss is in the middle of a long list of examples. In our work with the ISTH guidelines, we have tried to consider the important factors for both the surgeon and the patient. At the same time, it was necessary to create a definition that could not only be applied to most types of surgery represented in clinical trials using new anticoagulants, but also to keep it comparatively simple. The fact that both European and North American orthopedic and general surgeons could agree on these criteria was a big step forward. Although we admit that criterion no. 5 remains partly subjective, we find that the criterion suggested by Rosencher et al., ’all abnormal bleeding notified by the local investigator‘ is highly subjective and susceptible to influence by the knowledge that the patient is taking part in a trial with a new hemostatic agent. In trials, the local investigator is frequently not the operating surgeon. Who better than the surgeon present in the operating theatre, can assess what is unexpected (for the circumstances) and what represents prolonged bleeding? Some of us have been members of multiple committees for central event-adjudication for these studies, and we have often found that advice from the surgeon is the most helpful for gauging the seriousness of the wound bleeding and any likely association to study drug rather than to other bleeding risk factors. We, therefore, feel that the ISTH guideline for surgical patients is workable, in line with standard clinical practice and acceptable in any multicenter trial. A completely scientific and evidence-based process to develop ideal guidelines should select different strict criteria and prospectively evaluate their sensitivity for clinically important outcomes, including long-term function.
|
|
| 49. |
|
|
| 50. |
- Slepniov, D, et al.
(författare)
-
Understanding Innovation Spaces through Emerging Multinational Enterprises in China: An Explorative Case Study of a Chinese Wind Turbine Manufacture
- 2015
-
Ingår i: McKelvey, M. and Bagchi-Sen, S. (2015). Innovation Spaces in Asia: Entrepreneurs, Multinational Enterprises and Policy. - Cheltenham, U.K. : Edward Elgar Publishers. - 9781783475674 ; , s. 103-123
-
Bokkapitel (refereegranskat)abstract
- This chapter firstly provides a theoretical framing to explicitly relate the entrepreneur (individual) with the venture (company) to the national innovation system in China. The proposed framework defines an innovation space as a multifaceted organism not restricted geographically; but rather seen as consisting of multiple levels, including institutional, organisational and geographical aspects. This chapter also provides empirical insights of this journey from entrepreneurial venture to multinational enterprise, by focusing upon the process of expansion and internationalization of research and development of the Chinese wind turbine manufacturer. In doing so, the chapter provides a thick case description, with many details about the development of this Chinese company in the renewable energy industry. Right from its establishment in 2006, the company has been emphasizing the importance of innovation for its activities.
|
|
